Experimental drug cocktail aims to slow aggressive bladder cancer
NCT ID NCT01382706
Summary
This study tested whether combining a chemotherapy drug (docetaxel) with a pill that blocks cancer growth signals (lapatinib) could help control advanced bladder cancer that had worsened after initial platinum-based chemotherapy. The goal was to see if this combination could slow cancer progression better than past treatments. The trial was for adults with stage IV bladder cancer that could not be surgically removed and was terminated early.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
USC/Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
Conditions
Explore the condition pages connected to this study.